Simultaneous Determination of the N ?Dealkylated Metabolites of Four Butyrophenone?Type Agents in Rat Plasma by HPLC with Fluorescence Detection after Precolumn Derivatization with 4?Fluoro?7?Nitro?2,1,3?Benzoxadiazole
- 17 August 2007
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (18), 2747-2754
- https://doi.org/10.1080/10826070701560850
Abstract
The basic metabolites of butyrophenone type agents are sometimes more neurotoxic than the parent compounds. We have developed a high performance liquid chromatographic method with fluorescence detection (HPLC‐FL) to quantify the N‐dealkylated basic metabolites, i.e., 1,3‐dihydro‐1‐(1,2,3,6‐tetrahydro‐4‐pyridinyl) ‐2H‐benzimidazole‐2‐one, 1‐phenyl‐1,3,8‐triazaspiro[4.5]decan‐4‐one, 4‐(4‐chlorophenyl)‐4hydroxypiperidine, and 4‐(4‐bromophenyl)‐4‐hydroxypiperidine, of droperidol, spiperone, haloperidol, and bromperidol, respectively, in rat plasma after precolumn derivatization with 4‐fluoro‐7‐nitro‐2,1,3‐benzoxadiazole (NBD‐F). Mexiletine was carried through the procedure as an internal standard (IS). After liquid‐liquid extraction with benzene and evaporation, derivatization with NBD‐F was conducted in borate buffer (pH 8.5) at 60°C for 3 min. HPLC was conducted with a reversed‐phase (C18) column, eluted with a mixture of methanol‐water‐trifluoroacetic acid (600:400:0.4, v/v/v) at a flow rate of 1.0 mL/min at 25°C. The derivatives of four basic metabolites and the IS were well separated from each other in less than 48 min. The calibration curves were linear up to 0.5 µg/mL, and the lower limits of detection were 0.002 to 0.03 µg/mL. The coefficients of variation were less than 13.3%. These results confirm that HPLC‐FL after precolumn derivatization with NBD‐F is sensitive and satisfactory for the simultaneous assay of basic metabolites of four butyrophenone type agents in rat plasma.Keywords
This publication has 13 references indexed in Scilit:
- Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synucleinProceedings of the National Academy of Sciences of the United States of America, 2005
- Assessment of the Contributions of CYP3A4 and CYP3A5 in the Metabolism of the Antipsychotic Agent Haloperidol to Its Potentially Neurotoxic Pyridinium Metabolite and Effect of Antidepressants on the Bioactivation PathwayDrug Metabolism and Disposition, 2003
- Liquid chromatographic–mass spectrometric determination of haloperidol and its metabolites in human plasma and urineJournal of Chromatography B, 2002
- Comparison of SSI with APCI as an interface of HPLC-mass spectrometry for analysis of a drug and its metabolitesJournal of the American Society for Mass Spectrometry, 2002
- The characteristics of side‐effects of bromperidol in schizophrenic patientsPsychiatry and Clinical Neurosciences, 2002
- The Common Marmoset (Callithrix jacchus) as a Model for Neuroleptic-Induced Acute DystoniaPharmacology Biochemistry and Behavior, 1997
- Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparationsJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Freezing action of a metabolite of haloperidol in frogsBiochemical Pharmacology, 1992
- Metabolites of haloperidol display preferential activity at σ receptors compared to dopamine D-2 receptorsEuropean Journal of Pharmacology, 1990